Can having an ALK mutation change treatment in a 33-year-old?

Question

Hello doctor,

I am 33 years old and was diagnosed with lung cancer five months ago. The diagnosis came after my left lung partially collapsed, which was how they even found it. During the workup, they discovered that I have an ALK-positive mutation, which my oncologist said was actually “good news,” but I do not fully understand why.

I was started on Alectinib, and my breathing has improved since the lung was re-expanded with a chest drain, but I still get sharp pains on the left side, especially when breathing deeply. My pulmonologist did a repeat chest X-ray showing the lung is “mostly re-expanded,” but there is still a small effusion.

My liver enzymes have been slightly raised since starting Alectinib, and the doctor is monitoring them, but has not changed anything. I also started noticing swelling in my left leg, and a Doppler was ordered; I am waiting on the results, which is adding to everything.

How does having an ALK mutation actually change the whole treatment plan for someone my age with lung cancer? Does it mean the collapsed lung was because of the cancer directly? And is Alectinib something I will take forever, or are there better options coming?

Please advise.

Thank you.

Answer 1

Hello,

Welcome to icliniq.com.

I am deeply concerned about your worries.

At your age, finding an ALK (anaplastic lymphoma kinase)-positive mutation is actually an important advantage in terms of treatment. What your oncologist meant by “good news” is that this type of lung cancer responds very well to targeted medicines like Alectinib.

These drugs act directly on the abnormal pathway driving the cancer, so they are usually more effective and better tolerated than standard chemotherapy. In many patients, this allows long-term control of the disease with a good quality of life.

This finding completely changes the treatment plan. Instead of conventional chemotherapy, targeted therapy becomes the main treatment from the beginning. These medicines also have good control over disease spread, including areas like the brain, which is important in this type of cancer.

The collapse of your lung was most likely related to the cancer itself. This usually happens either because the tumor blocks part of the airway or because fluid collects around the lung, preventing it from expanding. The fact that your lung is now mostly re-expanded is reassuring, and a small residual fluid collection can take some time to resolve.

The sharp pain on deep breathing is something I commonly see after a lung has re-expanded or when there is some irritation of the lining of the lung. As long as your imaging is stable and there are no new findings, this type of pain usually improves gradually.

Mild elevation of liver enzymes with Alectinib is a known effect and is usually monitored rather than immediately changing treatment. If the rise remains mild, we continue the same medicine with regular follow-up tests. The swelling in your leg is an important symptom, and you have done the right thing by getting a Doppler test.

In patients with cancer, the risk of blood clots is higher, and if a clot is present, it can be treated effectively once confirmed.

As for Alectinib, it is generally continued as long as it is working and you are tolerating it well. There is no fixed duration. The positive aspect is that even if resistance develops later, there are newer targeted options available, so treatment does not stop at one drug.

Overall, your current treatment approach is appropriate, and the presence of an ALK mutation gives you a more precise and effective path forward compared to many other cases.

Hope I have addressed all of your queries and concerns.

Do follow up whenever needed.

Thank you.